Three-year efficacy and acceptability of the GyneFix® 200 intrauterine system

Contraception

Volumn 69, Issue 3, 2004, Pages 207-211

  Cao, Xiaoming ^a   Zhang, Wenhao ^a   Zhao, Xun ^a   Lin, Nong ^a   Wang, Limei ^a   Li, Chunhua ^a   Song, Lijuan ^a   Zhang, Weijia ^a   Zhang, Zhihong ^a   Wildemeersch, Dirk ^b,c  

^a Tianjin Munic Inst for Fam Plan   (China)

^b Gynecological Outpatient Clinic and IUD Training Center   (Belgium)

^c NONE   (Belgium)

Author keywords

Anchored IUS; Copper; Efficacy; Frameless IUS; GyneFix; Surface area; Tolerance

Indexed keywords

COPPER;

ANALYSIS; ARTICLE; BELGIUM; CHINA; CONTRACEPTION; CONTROLLED STUDY; DEVICE REMOVAL; FEMALE; FOLLOW UP; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUATION; NULLIPARA; PELVIC INFLAMMATORY DISEASE; PERFORATION; PREGNANCY; UTERUS;

EID: 10744229626     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2003.10.009     Document Type: Article

References (20)

1. Wildemeersch D., Batár I., Affandi B., et al. The 'frameless' intrauterine system for long-term, reversible contraception a review of 15 years of clinical experience . J Obstet Gynaecol Res. 29:2003;160-169.
2. The TCu380A IUD and the frameless "FlexiGard," interim three-year data from an international multicenter trial. Contraception. 52:1995;77-83.
3. Sturridge F., Guillebaud J. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system. Drug Safety. 15:1996;430-440.
4. Martinez F., Gimenez E., Hérnandez G., et al. Experience with GyneFix® favorable acceptance of the intrauterine contraceptive implant with some limitations . Contraception. 66:2002;315-320.
5. Wagner H. Intrauterine contraception: past, present and future. Rabe T., Runnebaum B. Fertility control: update and trends. 1999;151-171 Springer, Berlin, Germany.
6. Odlind V. Disturbances of bleeding with intrauterine contraceptive devices and hormonal intrauterine systems. Cameron I.T., Fraser I.S., Smith S.K. Clinical disorders of the endometrium and menstrual cycle. 1998;390-398 Oxford University Press, Oxford (UK).
7. Trussell J., Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use results from the 1995 National Survey of Family Growth . Fam Plann Perspect. 31:1999;64-72.
8. Andrade A.T.L., Pizarro Orchard E. Quantitative studies on menstrual blood loss in IUD users. Contraception. 36:1987;129-144.
9. World Health Organization (WHO). More than half of all pregnant women suffer from anaemia. WHO Press Release WHO/17, 3 March 1993.
10. Andrade A.T.L., Pizarro Orchard E. Quantitative studies on menstrual blood loss in IUD users. Contraception. 36:1987;129-144.
11. 2: an interim analysis. Contraception 2002;66:237-41.
12. SAS user's guide basics, version 5 edition . 1985;SAS Institute Inc, Cary (NC).
13. Mishell D.R. Intrauterine devices. Fertil Contr Rev. 3:1992;3-12.
14. Rowe P.J. Clinical performance of copper IUDs. A new look at IUDs - Advancing contraceptive choices. Bardin C.W.B., Mishell D.R. Jr. Fourth Conference on IUDs. 1992;13-31 Butterworths-Heinemann, Boston (MA).
15. Kosonen A. Corrosion of copper in utero. Hafez E.S.E., van Os W. Medicated intrauterine devices. 1980;22-29 Martinus Nijhoff, The Hague, The Netherlands.
16. Chantler E.N. Copper loss from copper IUDs. Zatuchni G.I., Goldsmith A., Sciarra J.J. Intrauterine contraception: advances and future prospects. 1984;198-210 Harper and Row, Philadelphia (PA).
17. UNDP, UNFPA and WHO Special Programme for Research, Development and Research Training in Human Reproduction, World Bank: IUD Research Group. The TCu380A IUD and the Frameless "FlexiGard," Interim Five-Year Data from an International Multicenter Trial. (Dr Rowe, personal communication).
18. Janssen C.A., Scholten P.C., Heintz A.P.M. A simple visual assessment technique to discriminate between menorrhagia an normal menstrual blood loss. Obstet Gynecol. 85:1995;977-982.
19. Andrade ATL, Araujo DAC, Andrade GN, Wildemeersch D, Rowe PJ. Menstrual blood loss with "frameless" copper-, copper-levonorgestrel- and levonorgestrel-releasing intrauterine systems. Contraception (submitted).
20. European guideline EN ISO 7439:2001 E, Copper-bearing intra-uterine devices, Requirements, tests. ICS 11.200.